Literature DB >> 18194819

4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.

A Sam Beddar1, Tina Marie Briere, Peter Balter, Tinsu Pan, Naresh Tolani, Chaan Ng, Janio Szklaruk, Sunil Krishnan.   

Abstract

We have developed a tumor-specific protocol for the 4D-CT imaging of liver tumors using synchronized intravenous (IV) contrast injection to improve the accuracy of tumor delineation for treatment planning. Most liver metastases and cholangiocarcinomas can be imaged in the portal venous phase, while hepatocellular carcinomas are most visible in the delayed phase. Combined 4D-CT imaging with synchronized IV contrast allows for both enhancement of tumor contrast and coverage over the entire breathing cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194819     DOI: 10.1016/j.radonc.2007.12.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  24 in total

Review 1.  Charged-particle therapy for hepatocellular carcinoma.

Authors:  Heath D Skinner; Theodore S Hong; Sunil Krishnan
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  Imaging and image-guided radiation therapy in liver cancer.

Authors:  Kristy K Brock
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

3.  Use of combined maximum and minimum intensity projections to determine internal target volume in 4-dimensional CT scans for hepatic malignancies.

Authors:  Jin Liu; Jia-Zhou Wang; Jian-Dong Zhao; Zhi-Yong Xu; Guo-Liang Jiang
Journal:  Radiat Oncol       Date:  2012-01-30       Impact factor: 3.481

4.  Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.

Authors:  Awalpreet S Chadha; Jillian R Gunther; Cheng-En Hsieh; Maureen Aliru; Lakshmi S Mahadevan; Bhanu P Venkatesulu; Christopher H Crane; Prajnan Das; Joseph M Herman; Eugene J Koay; Cullen Taniguchi; Emma B Holliday; Bruce D Minsky; Yelin Suh; Peter Park; Gabriel Sawakuchi; Sam Beddar; Bruno C Odisio; Sanjay Gupta; Evelyne Loyer; Harmeet Kaur; Kanwal Raghav; Milind M Javle; Ahmed O Kaseb; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2019-01-16       Impact factor: 6.280

5.  Simplified strategies to determine the mean respiratory position for liver radiation therapy planning.

Authors:  Michael Velec; Joanne L Moseley; Kristy K Brock
Journal:  Pract Radiat Oncol       Date:  2013-08-08

Review 6.  Technical advances in external radiotherapy for hepatocellular carcinoma.

Authors:  Shin-Hyung Park; Jae-Chul Kim; Min Kyu Kang
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 7.  Adaptive management of liver cancer radiotherapy.

Authors:  Kristy K Brock; Laura A Dawson
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

8.  Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).

Authors:  E Gkika; S Tanadini-Lang; S Kirste; P A Holzner; H P Neeff; H C Rischke; T Reese; F Lohaus; M N Duma; K Dieckmann; R Semrau; M Stockinger; D Imhoff; N Kremers; M F Häfner; N Andratschke; U Nestle; A L Grosu; M Guckenberger; T B Brunner
Journal:  Strahlenther Onkol       Date:  2017-07-10       Impact factor: 3.621

9.  Asymmetric margin setting at the cranial and caudal sides in respiratory gated and non-gated stereotactic body radiotherapy for lung cancer.

Authors:  Yoshihiro Ueda; Shingo Oohira; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima
Journal:  Br J Radiol       Date:  2015-12-23       Impact factor: 3.039

10.  4D liver tumor localization using cone-beam projections and a biomechanical model.

Authors:  You Zhang; Michael R Folkert; Bin Li; Xiaokun Huang; Jeffrey J Meyer; Tsuicheng Chiu; Pam Lee; Joubin Nasehi Tehrani; Jing Cai; David Parsons; Xun Jia; Jing Wang
Journal:  Radiother Oncol       Date:  2018-11-14       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.